The global laboratory proficiency testing market size was valued at USD 1.42 Billion in 2024 and is expected to grow from USD 1.52 Billion in 2025 to reach USD 2.65 Billion by 2033, exhibiting a CAGR of 7.2% during the forecast period (2025–2033). The growth in the laboratory proficiency testing market is driven by increasing regulatory demands for accuracy and quality assurance, alongside the adoption of advanced technologies and digital platforms to enhance testing efficiency and standardization.
Laboratory proficiency testing is a quality assurance procedure to assess the reliability and accuracy of a laboratory's analytical results. In this procedure, laboratories compare the results of samples with known values to the anticipated results. This testing guarantees that laboratories consistently generate reliable and precise results that comply with established standards. It is an essential instrument for the preservation of high laboratory performance standards and the improvement of the credibility of test results.
Proficiency testing programs increasingly cover various diagnostic fields and specialized tests. This expansion includes launching new and revised surveys to meet diverse diagnostic requirements, exemplified by the updated Molecular Microbiology (MOLE-STI) survey and enhanced cytopathology assessments. This trend improves diagnostic precision and provides advanced training opportunities across various medical specialties.
This trend indicates a broader approach to proficiency testing, addressing more specific and diverse diagnostic requirements and responding to the need for enhanced accuracy and training across various medical disciplines.
Adopting digital platforms for managing proficiency testing programs is a key market trend, gaining traction as laboratories seek more efficient and standardized processes. These platforms simplify the workflow, from test result submission to data analysis and reporting, enabling laboratories to participate in proficiency testing remotely. This transition improves the efficiency of testing processes and provides real-time feedback, allowing laboratories to promptly address any issues and maintain high standards of accuracy and quality.
To get more insights about this report Download Free Sample Report
Stringent safety and quality regulations imposed by regulatory authorities worldwide significantly drive growth in the laboratory proficiency testing market. These regulations are designed to prevent contamination and ensure the safety of food and pharmaceutical products, thereby protecting public health. As a result, there is a growing demand for proficiency testing services to ensure that laboratories comply with these rigorous standards.
These guidelines require regular proficiency testing to verify that laboratories can consistently produce accurate and reliable results. The increasing enforcement of these regulations has significantly boosted the proficiency testing market, as laboratories are compelled to participate in proficiency testing programs to maintain their accreditation and meet regulatory requirements.
The surge in introducing disease-specific testing initiatives to address the rising complexity and diversity of diseases that laboratories encounter is a crucial driver for market growth. Disease-specific proficiency testing ensures that diagnostic processes are precise and reliable, especially as new pathogens and conditions emerge.
This focus on disease-specific proficiency testing helps laboratories stay up-to-date with emerging health threats, supports regulatory compliance, and improves overall diagnostic accuracy. It also highlights the industry's proactive approach to addressing diagnostic needs and public health challenges.
The growing reliance on proficiency testing by accreditation bodies to ensure laboratory credibility imposes substantial financial burdens on laboratories. The costs involved in proficiency testing are multi-faceted, encompassing program preparation, sample processing, handling, and reporting. These stages necessitate advanced technologies such as liquid chromatography-mass spectrometry (LC-MS/MS) systems. Although this equipment can detect and quantify many substances, it is a significant capital expenditure. The initial purchase cost, ongoing maintenance, and the need for highly skilled technicians to operate and calibrate the equipment contribute to the financial burden. Additionally, laboratories may require specialized data analysis and interpretation software, further increasing costs.
Proficiency testing for genetic disorders faces significant logistical challenges due to the rarity of many conditions and the limited number of specialized laboratories performing these tests.
Emerging economies such as China, India, and South Korea present the laboratory proficiency testing market with substantial development opportunities. These countries provide benefits such as rapid growth in the pharmaceutical and food sectors, minimal labor costs, and fewer stringent regulations. The increasing prevalence of chronic and infectious diseases increased disposable incomes, and the expansion of healthcare access drives the demand for proficiency testing.
Furthermore, market potential is further enhanced by investments in healthcare infrastructure and initiatives to obtain international laboratory accreditations. Companies can capitalize on these trends by offering customized proficiency testing services that are customized to the changing requirements of laboratories in these expanding markets. Additionally, the anticipated growth in demand is expected to be further fueled by the growing emphasis on enhancing healthcare quality and laboratory standards in these regions, which will open up new opportunities for market expansion.
North America maintains its position as the leading laboratory proficiency testing market due to its advanced healthcare infrastructure, stringent regulatory requirements, and substantial investments in technology. The region's emphasis on high diagnostic accuracy and quality assurance standards drives the demand for comprehensive proficiency testing services. North American countries, particularly the United States, have well-established regulatory frameworks that mandate rigorous proficiency testing to ensure the reliability of diagnostic results.
The Asia-Pacific region is expected to grow at the highest CAGR over the forecast period due to the rising prevalence of chronic and infectious diseases, which drives demand for accurate diagnostics. Additionally, increased awareness and adoption of international standards and certifications promote proficiency testing. Furthermore, due to low labor costs and high-quality products, the region is becoming a hub for international biopharmaceutical and pharmaceutical companies. This makes continuous laboratory testing of raw materials, finished products, and microbial cultures crucial for production and FDA approval, further fueling market expansion.
In 2023, the cell culture segment dominated the laboratory proficiency testing market. This is driven by the increasing adoption of cell culture-based products, such as monoclonal antibodies, which has heightened the demand for cell culture tests to optimize microbial strain cultures. In this area, proficiency testing (PT) is crucial for evaluating laboratory performance and identifying contaminants, including impurities in cell cultures. Minerva Biolabs GmbH is a crucial provider of proficiency tests tailored specifically to assess common contaminants and evaluate a laboratory's sensitivity to yeast/fungi, bacteria, and mycoplasmas, reinforcing the importance of cell culture PT in ensuring high-quality biotechnological products.
However, the chromatography segment is anticipated to grow at the highest CAGR during the forecast period. The increasing need to ensure the efficacy of chromatography devices and the reliability of test results is driving demand for proficiency test materials in this segment.
In 2023, clinical diagnostics lead the market due to their crucial role in enhancing drug delivery, primarily due to the high demand for accurate and reliable testing in healthcare. This segment's dominance is driven by the critical need for proficiency testing to ensure the quality of diagnostic tests used in patient care, such as blood tests, molecular diagnostics, and infectious disease screening.
To get more findings about this report Download Market Share
Per our analyst, the laboratory proficiency testing market is experiencing robust growth driven by advancements in testing technologies and increasing regulatory pressures. The demand for precise and reliable test results across various sectors, including healthcare, environmental, and food safety, is pushing laboratories to adopt more sophisticated proficiency testing programs. Emerging markets, particularly in Asia Pacific, are rapidly expanding due to rising investments in healthcare infrastructure and growing awareness of quality standards. Additionally, integrating AI and machine learning into testing processes enhances the accuracy and efficiency of proficiency testing, offering new opportunities for market revenue growth and innovation. These trends contribute significantly to the overall market revenue, positioning proficiency testing as critical in maintaining high standards and compliance across industries.
| Report Metric | Details |
|---|---|
| Market Size in 2024 | USD 1.42 Billion |
| Market Size in 2025 | USD 1.52 Billion |
| Market Size in 2033 | USD 2.65 Billion |
| CAGR | 7.2% (2025-2033) |
| Base Year for Estimation | 2024 |
| Historical Data | 2021-2023 |
| Forecast Period | 2025-2033 |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
| Segments Covered | By Technology, By Industry Type, By Region. |
| Geographies Covered | North America, Europe, APAC, Middle East and Africa, LATAM, |
| Countries Covered | U.S., Canada, U.K., Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Singapore, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia, |
Explore more data points, trends and opportunities Download Free Sample Report
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
Speak To AnalystAvailable for purchase with detailed segment data, forecasts, and regional insights.
Get This Report